Distribution of almost €400 million authorized for the High-End Technology Equipment

17

Jun 2022

On May 31, 2022, it was announced by the Ministry of Health that the Council of Ministers authorized the distribution of almost €400 million for the renovation of high-tech equipment in the National Health System (SNS) through the High-End Technology Equipment Investment Plan (INVEAT) of the SNS. This adds to almost €400 million approved for this purpose in 2021. Following authorization by the Council of Ministers, this distribution agreement will be submitted for approval by the Interterritorial Council for the National Health System (CISNS).

For the years 2021-2022, the renovation of equipment amounts to 574 units and the expansion to 277. The portfolio of equipment to be renewed or expanded has included linear accelerators, CT, magnetic resonance imaging, PET-CT, gamma cameras, digital brachytherapy equipment, vascular angiographs, neuroradiology angiographs, and catheterization laboratories.

It is expected that the INVEAT will reduce the obsolescence of the current SNS technology park and raise the average density rate of high-tech equipment per 100,000 inhabitants by at least 15%.

The full details in Spanish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

23

Jun 2022

On May 31, 2022, Regional Cancer Centers collaboration (RCC) updated the national care program for breast cancer. New and updated recommendations concerned genetic testing, molecular diagnostic, de-escalation of surgical treatment for certain patient groups, radiotherapy regimens, and pharmacotherapy. A new chapter was added on breast cancer in men.

Read more

14

Jun 2022

On May 31, 2022, a decision of the National Union of Health Insurance Funds relating to the update of the Nomenclatures of procedures - Common classification of medical procedures (CCAM) and General nomenclature of professional acts (NGAP) - was published in the Official Journal of the French Republic. Various changes were introduced in the CCAM, such as the inclusion of new procedure codes, provisionally registered codes, and modification of the billing conditions. New CCAM codes were introduced in the field of ophthalmology, men’s health, and diagnostic imaging. These changes will be reflected in version 70 of the CCAM nomenclature, which will enter into force on June 30, 2022.

Read more

01

Jun 2022

The French National Authority for Health released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies in May 2022. Thirty-one recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services. Opinions concern cardiovascular and peripheral vascular, diagnostic imaging, interventional radiology, orthopedic, neurovascular and neuromodulation, endocrine and E-health devices, as well as medical aids.

Read more

31

May 2022

In May 2022, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (endoanchoring systems in endovascular aortic aneurysm repair, supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis, personalized external aortic root support using mesh in people with Marfan syndrome), one Medical Technologies Guidance (Sleepio to treat insomnia and insomnia symptoms), and six Medtech innovation Briefings (ViewSite Brain Access System, Granulox for managing chronic wounds, AMBLor for identifying melanomas, Bladder EpiCheck for detecting bladder cancer recurrence, and others). No MedTech-related clinical guidelines were published.

Read more

26

May 2022

In April 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced two projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a transcatheter tricuspid valve repair in severe leakage of the tricuspid valve and precision radiation in epilepsy. In total, five projects will receive a subsidy in 2022.

Read more